The 2nd International Conference on Drug Discovery & Therapy: Dubai, February 1 - 4, 2010


Tentative Conference Program

2nd INTERNATIONAL CONFERENCE ON
DRUG DISCOVERY AND THERAPY
February 1– 4, 2010, Dubai Men’s College, Dubai, UAE
Quick Links:





TIME NAME OF SPEAKER
9.45 a.m.`

Delegates to be seated
10.15 a.m.
10:30 a.m.

Arrival of Chief Guest and VIPs in the Majlis
10.30 a.m.

National Anthem
10.33 a.m.

A HCT student MC welcomes the delegates
10:34 a.m.

MC to invite H.E. to deliver the Opening Address
10.35 a.m.

Opening address - H.E. Sheikh Nahayan Mabarak Al-Nahayan (Patron 2nd ICDDT)
10.50 a.m.

Conference co-President's welcome address - Prof. Dr. Atta-ur-Rahman, FRS
11.00 a.m.

Keynote Address of Prof. Dr. Ferid Murad, (Nobel Laureate & co-President, 2nd ICDDT)
11.15 a.m.

Vote of Thanks by the student MC
11.20 a.m.

Opening of the Exhibition by Sheikh Nahayan


COFFEE BREAK & TOUR OF EXHIBITION BY VIPs : 11:20 a.m. - 12:00 noon
Plenary Session
Time Chairman: Ferid Murad
Co-Chairman: Atta-ur-Rahman
Speaker
Title
12:00
12:45
p.m.
Location: Auditorium  Robert Huber (Nobel Laureate)
PL-1 Intracellular Proteolysis, Basic Science and Application
12:45
01:30
p.m.
Location: Auditorium  Allen B. Reitz
PL-2 The Challenge of Drug Discovery in the 21st Century

LUNCH BREAK : 1:00 - 2:30 p.m.
Time
Auditorium
Lecture Hall No.
L-115
Lecture Hall No.
E-204/205
Lecture Hall No.
B-250
Lecture Hall No.
B-114-116
Lecture Hall No. 6
(Business Faculty Area)
Lecture Hall No.
B-122
Lecture Hall No. 8
(Engineering Faculty Area)
 
 Drug Delivery Enabling Technologies Global Roundup of Pharmaceutical Research Capabilities and Opportunities/Successful Drug Discovery from the Research Lab to the Marketplace Oncology Endothelial Dysfunction in Cardiovascular Diseases/Nanotechnology in Biomedical Research Anti-Infectives

 Translational Biomedical Research

 Central Nervous System
 
 Chairman: H. Kasuya
Co-Chairman: D. Djian 		Chairman: S.K. Sahoo
Co-Chairman: E. Jaffe 		Chairman: A.B. Reitz
Co-Chairman: J. Guerrero 		Chairman: D.L. Vesely
Co-Chairman: R. Kumar
 Chairman: E. Domingo
Co-Chairman: P. Mabeta
 Chairman: F.G. Njoroge
Co-Chairman: M.I. Choudhary

Chairman: J. Chandra
Co-Chairman: N.J.R. Faria

Chairman: P.A. Guertin
Co-Chairman: M. Diksic

2:30 3:00 p.m.
 K. Alexandrov

Prenylome and Lipid Modifications 		IL-3 W. Duan

Aptamer Therapeutics: The 21st Century's Magic Bullet of Nanomedicine		 IL-4 B.M. Dunn

Global Infectious Diseases: The Potential for Protease Inhibitors in Developing New Therapeutics 		IL-5 E. Arinc

Polymorphic Cytochrome P450 Enzymes: Challenges for Anticancer Drug discovery and Development 		IL-6 N.H. Hadi

 Erectile Dysfunction as a Predictor of Cardiovascular Disease		 IL-7 J. Rello

 The Number of New Agents in the Pipeline is Scarce 		IL-8 T. E. Adrian

Translational Research from a Basic Science Perspective - Development of Novel Therapeutics for Cancer, Diabetes and Obesity		 IL-9 F.C. Acher


Orthosteric Agonists of Group III Metabotropic Glutamate Receptors (mGluR). From Virtual Screening to Potential Therapeutic Effects 		IL-10
3:00 3:30 p.m.
 V. Kessler

Metal Oxide Micro and Nanoparticles for Application in Targeted Drug Delivery 		IL-11 M. Yamamoto

The Roles of High-Brilliant Synchrotron Radiation in Macromolecular Crystallography		 IL-12 L.J.S. Knutsen

 GabitrilTM – A Drug for the Treatment of Partial Seizures Acting via Inhibition of GABA Uptake		 IL-13 N. Ben-Jonathan

Small Molecule Inhibitors of the Prolectin Receptor in Breast Cancer 		IL-14 N. Jessel

Nanostructured and Multilayered Active Materials for Clinical Applications		 IL-15 T.K. Warren

Advancement of Antisense Therapy for Filovirus Infections		 IL-16 D.K. Lahiri

Current Pharmacogenomics & Epigenetic Studies in Neuropsychiatric Disorders		 IL-17 G G. Yener

 Brain Oscillations in Alzheimer's Disease and Their Modulation by Cholinesterase Inhibitors		  IL-18
COFFEE BREAK : 03.30 – 4.00 p.m.
Time
Auditorium
Lecture Hall No.
L-115
Lecture Hall No.
E-204/205
Lecture Hall No.
B-250
Lecture Hall No.
B-114-116
Lecture Hall No. 6
(Business Faculty Area)
Lecture Hall No.
B-122
Lecture Hall No. 8
(Engineering Faculty Area)
 
 Drug Delivery/ Drug Discovery and Therapy in the Middle East: Challenges and Opportunities Enabling Technologies Cardiovascular Oncology Nanotechnology in Biomedical Research/Biologics Anti-Infectives

Diabetes & Obesity/Proteomics & Bioinformatics

Pharmaceutical Biotechnology/Developments in Other Therapeutic Areas/Successful Drug Discovery from the Research Lab to the Marketplace
 
 Chairman: R. Mezzenga
Co-Chairman: T. Al-Tel 		Chairman: A. Persidis
Co-Chairman: S. Fredriksson 		Chairman: U. Desai
Co-Chairman: D.P. Ramji 		Chairman: E. Arinc
Co-Chairman: P. Gunning 		Chairman: N. Jessel
Co-Chairman: F.C. Onwuka
 Chairman: J. Rello
Co-Chairman: T.K. Warren

Chairman: S.P. Kalra
Co-Chairman: H. Durchschlag

 Chairman: D.F. Maurizio
Co-Chairman: O.L. Franco

4:00
4:30
p.m
 H. Kasuya

Development of Nicardipine Prolonged-Release Implants after Clipping for Preventing Cerebral Vasospasm: From Laboratory to Clinical Trial 		IL-19 S. K. Sahoo

Application of Nanomedicine: As an Emerging Platform for Cancer Therapy		 IL-20 I.M. Khachigian

 Preclinical Analysis of Dnazymes Suppressing Cancer Growth, Metastasis and the Development of Other Vascular Diseases 		IL-21 H. Yoshikawa

 Application of Direct DNMT3A Inhibition to the Development of Inhibitors for Cancer-specific CpG Island Methylation		 IL-22 T. LaBean

Self-Assembling DNA Nanostructures for Biomedical Applications		 IL-23 F. G. Njoroge


From Bench to Bedside: Discovery of Boceprevir, a novel antiviral agent for treatment of Hepatitis C Virus		 IL-24 B. Fromenty

Recent Discovery of the Effects of Beta-Aminoisobutyric Acid on Lipid Homeostatis. Mechanisms and Possible Relevance for the Prevention of Obesity		 IL-25 K. Yasuda

On-Chip Pre-Clinical Cardiac Toxicity: Testing Compounds Beyond hERG and QT using hES/hips Cardiomyocyte Cell Network Re-Entry Model on a Chip		  IL-26
4:30
5:00
p.m.
 P. Djian

Transglutaminase and Linkage of Active Agents to Tissues		 IL-27 E. Jaffe

Morpheeins-A New Pathway for Allosteric Drug Discovery		 IL-28 P.L. Huang

Oleuropein and Related Compounds from Olive Plants Reduce Diet-Induced Atherosclerosis in apoE Knockout Mice		 IL-29 D.L. Vesely

Four New Anticancer Drugs: Cardiovascular Hormones Treatment of Human Pancreatic, Breast and Small Cell Lung Cancers in Athymic Mice		 IL-30 P. Mabeta

Nanoparticle-Based Chemotherapy Inhibits Tumor-Associated Angiogenesis in a Murine Vascular Tumor Model		 IL-31 M.I. Choudhary

 Discovery of Natural Anti- Infectives		 IL-32 S. Lee-Huang

Oleuropein and Related Compounds from Olive Plants Modulate Adipogenesis		 IL-33 R. Raghu

 Structure Based Pharmacophore Design in Computer Aided Drug Discovery		 IL-34 
5:00
5:30
p.m.
 R. Chaguturu

Emerging Trends in the Discovery and Development of Chemical Probes Against Novel Therapeutic Targets in Academia: A Mount Everest in the Making		 IL-35 J.M. Brunel
Title Awaited		 IL-36 J.D. Baxter

Development of Pharmaceuticals that Exploit the Thyroid Hormone Receptor 		IL-37 A. Cherkasov
Title Awaited		 IL-38 C. Godwin

Prevalence of Candida albicans Associated Gastroenteritis in Nigerian Children		 IL-39 G. Gupta

Protection Against Pathogen Infection by Boosting Host Innate Immunity		 IL-40 P. Hobza

“In Silico” Drug Design Based on the Modified Semi-Empirical Quantum Chemical PM6 Method		 IL-41 T. Tallberg

Bio-Immunotherapy, A combined Biological and Immunological Cancer Therapy Modality		  IL-42
5:30
5:50
p.m.
 C. Braeuchle

Drug Delivery: Observation of Nanoparticle Internalization and Gene Delivery by Live Cell Imaging		 SL-43 M. Barton
Title Awaited		 SL-44 H.I. Vapaatalo

Does the Rennin - Angiotensin System (RAS) Regulate Also Intraocular Pressure (IOP)?		 SL-45 H.I. Vapaatalo
Title Awaited		 SL-46 E. Osaro


The Effects of Highly Active Antiretroviral Therapy of Stavudine, Lamivudine and Nevirapine on the CD4 Lymphocyt E Count of HIV-Infected Africans: The Nigerian Experience		 SL-47 L. Polonelli

Antibodies are Cryptic Reservoirs of Antiinfective, Antitumor and Immunomodulatory Peptides		 SL-48 C.O. Alebiosu

Assessing the Degree of Success for Attaining Clinical Goals Among People Living with Diabetes in a Nigerian Teaching Hospital		 SL-49 A.Nefzi

 Combinatorial Chemistry for the Rapid Identificatin of Highly Active Compounds		  SL-50

Posters Session: 1:00 p.m. - 5:00 p.m. at corridor

Conference Social Mixer: 6:30 - 7:00 p.m.

The buses will leave for hotels at 7:15 p.m.








Plenary Session
Time Chairman: R. Huber
Co-Chairman: C.D. Ribas
Speaker
Title
09:00
9:45
a.m.
Location: Auditorium Gordon Wallace
PL-51		 PL-51 Printing, Spinning and Weaving our Way into a New World of Delivery Systems
9:45
10:30
a.m.
Location: Auditorium Atta-ur-Rahman
PL-52		 PL-52 Natural Products -- An Exciting Source of New Drugs and Pharmacophores


COFFEE BREAK: 10:30 – 11:00 a.m.
Time
Auditorium
Lecture Hall No.
L-115
Lecture Hall No.
E-204/205
Lecture Hall No.
B-250
Lecture Hall No.
B-114-116
Lecture Hall No. 6
(Business Faculty Area)
Lecture Hall No.
B-122
Lecture Hall No. 8
(Engineering Faculty Area)
 
 Drug Delivery/ Central Nervous Systems Enabling Technologies Cardiovascular/ Translational Biomedical Research Oncology Global Roundup of Pharmaceuticals Research Capabilities and Opportunities/Endothelial Dysfunction in Cardiovascular Diseases Successful Drug Discovery from the Research Lab to the Marketplace

 Translational Biomedical Research/Diabetes & Obesity

 Pulmonary Disorders
 
 Chairman: K. Alexandrov
Co-Chairman: A.C. Acher 		Chairman: G. Wallace
Co-Chairman: W. Duan 		Chairman: P.L. Huang
Co-Chairman: M. Delmar 		Chairman: N. Ben-Jonathan
Co-Chairman: E.Terpos 		Chairman: B.M. Dunn
Co-Chairman: R.A. Torres 		Chairman: L.J.S. Knutsen
Co-Chairman: R. Rezzani

Chairman: T.E. Adrian
Co-Chairman: S. Lee-Huang

Chairman: S.A. Fontana
Co-Chairman: J. Ho

11:00
11:30
a.m.
R. Mezzenga

Self-Assembled Food Mesophases as Delivery Systems in Water Environment: State of the Art & Challenges 		IL-53 S. Fredriksson

Sensitive and High Throughput Multiplexed Immunoassays for Biomarker Discovery in Biobanked Samples Using Proximity Ligation Assays and qPCR		 IL-54 D.P. Ramji

The Monocyte/Macrophage as a Promising Therapeutic Target for Atherosclerosis		 IL-55 P. Gunning

 Development of a New Class of Anti-Cancer Chemotherapeutics which Target the Actin Cytoskeleton 		IL-56 K. Stromgaard

 Conversion of Natural Toxins such as the Mushroom Toxins Muscimol and Ibotenic Acid into Glutamate Receptor Ligands 		IL-57 B.J. Sargent

 ALB 109564 - A Novel Tubulin Inhibitor 		IL-58 J. Lewis

 Translational Research in Cancer: Programs of Multi-Institutional University and Industry Collaboration in Drug Discovery and Development		 IL-59 C.D. Ribas

 Alternatives to Oral Corticosteroids in Gina Step V Asthma Patients		 IL-60
11:30
12:00
noon
A. Banga

New Technologies to Allow Transdermal Delivery of Biopharmaceuticals 		IL-61 A. Persidis

Literature Based Discovery: The Biovista Platform for Clinical Outcomes Analysis		 IL-62 U. Desai

Rational Design of Non-Saccharide Mimetics of Heparin 		IL-63 B. Tomanek

Early Tumor Growth Affects Diagnosis and Efficacy of Molecular MRI 		IL-64 K. Chibale

Discovering Drugs in Africa by Africans: Challenges and Opportunities		 IL-65 J. Hutchison

Avotermin (Juvista ) - A Novel Drug in a New Therapeutic Field		 IL-66 J. K. Yao

Phospholipids Turnover and Arachidonate Signaling in Schizophrenia		 IL-67 A. Linden


Targeting Interleukin-17A - An Orchestrator of Neutrophil Mobilization in the Lungs		 IL-68
12:00
12:30
p.m.
M. Hajos

Endophenotypes as Drug Targets in Psychiatric Disorders: Connecting Genetics to Pathophysiology 		IL-69 S. Stahl

 Affibody-Mediated Tumor Targeting for Medical Imaging and Radiotherapy Applications		 IL-70 D. Garcia-Dorado

Myocardial Repurfusion Injury: An Emerging Field for Drug Therapy in Cardiovascular Disease		 IL-71 V.M. Rangnekar

A Paradigm for Cancer Selective Apoptosis 		IL-72 E. Domingo

New Concepts in the Invasive Evaluation of Remodeling of the Right Ventricle and Pulmonary Vasculature in Pulmonary Arterial Hypertension: Future Targets for Drug Evaluation		 IL-73 L.F. Rodella

New Perspective in Pain Treatment		 IL-74 N.A. Khan

Dietary Fatty Acids in the Management of Gestational Diabetes Mellitus (GDM) and Macrosomia		 IL-75 P. Paggiaro

 Pharmacologic Strategies for Asthma Management		 IL-76
12:30
01:00
p.m.
P. George

The Challenges of the CNS Medicinal Chemist. The Traps to Avoid		 IL-77 A. A. Oraevsky

 Systems and Biomedical Applications of Optoacoustic Tomography		 IL-78 A.R.K. Franklin

 Extended Spectrum of Activity of Forodesine, A Purine Nucleoside Phosphorylase Inhibitor		 IL-79 K. Moelling

 Antiangiogenic Effect of Plasmid DNA Encoding Human Interleukin-12 in Metastatic Melanoma Patients and Combination Therapy		 IL-80 J. Freund

Titlle Awaited
 IL-81 R.J. Reiter

Light as a Drug: Circadian Disruption, Melatonin Suppression and Cancer		 IL-82 S.P. Kalra

Gene-Transfer Technology to Combat Metabolic Disease Cluster for Lifetime		 IL-83 R. Mora-Ripoll

Omalizumab in the Management of Patients with Allergic (IgE-Mediated) Asthma		 IL-84
LUNCH BREAK : 1:00 - 2:30 p.m.
Time
Auditorium
Lecture Hall No.
L-115
Lecture Hall No.
E-204/205
Lecture Hall No.
B-250
Lecture Hall No.
B-114-116
Lecture Hall No. 6
(Business Faculty Area)
Lecture Hall No.
B-122
Lecture Hall No. 8
(Engineering Faculty Area)
 
 Drug Delivery Enabling Technologies/ Successful Drug Discovery from the Research Lab to the Marketplace/Inflammation & Immunology Cardiovascular Oncology Nanotechnology in Biomedical Research Anti-Infectives

 Translational Biomedical Research/Diabetes & Obesity

 Pulmonary Disorders/Inflammation & Immunology
 
 Chairman: V. Kessler Co-Chairman: P. Thordarson Chairman: P. Watt
Co-Chairman: A.A. Oraevsky 		Chairman: J.D. Baxter Co-Chairman: X.L. Zheng Chairman: S. Pervaiz
Co-Chairman: M. Hassan 		Chairman: T. LaBean
Co-Chairman: N.Jessel 		Chairman: G. Gupta
Co-Chairman: B.L. Tekwani		 Chairman: B. Fromenty
Co-Chairman: H.M. Amin

Chairman: P. Paggiaro
Co-Chairman: R. Mora-Ripoll
2:30
2:50
p.m.
G. Fricker

Drug Delivery to the Brain by Polymeric Nanparticles 		SL-85 A.K. Pantazis

Novel Acoustic Sensors for Clinical Applications		 SL-86 J.E. Baker

Thrombopoietin is a Novel Cardioprotective Agent: Proofs of Concept Studies in Animal and Human Hearts		 SL-87 M. Melnik

Copper(II) Carboxylates as a Perspective Cytotoxic Agents		 SL-88 R. Katona

 A Combined Artificial Chromosome-Stem Cell Therapy Method for the Treatment of Krabbe's Disease in the Twitcher Mouse 		SL-89 S. Hasnain

 Bacteria Exhibiting Antimicrobial Activities: Screening for Antibiotics and the Associated Genetic Studies 		SL-90 J. Boklan

 Targeting Tots: Challenges in Pediatric Cancer Drug Development		 SL-91 S.A. Fontana
Pulmonary Drugs from the Sea		 SL-92
2:50
3:10
p.m.
B. Geusens

SECosomes for Delivery of siRNA into Cultured Primary Melanocytes and Ex Vivo Human Skin		 SL-93 I.A. Mikhailopuloo

A New Strategy for the Synthesis of Nucleosides: One-Pot Enzymatic Transformation of Pentoses into Nucleosides		 SL-94 J. Cui

 The Voltage Sensors in IKs Channels May be an Ideal Drug Target for Cardiac Arrhythmias 		SL-95 T. Yau

Molecular Targeted Therapy for Advanced Hepatocellular Carcinoma		 SL-96 M.I. Naash

Compacted DNA Nanoparticles, A Non-Viral Gene Delivery for Ocular Diseases		 SL-97 F.C.P. Law

Development and Validation of a Physiologically Based Pharmacokinetic (PBPK) Model of Tamiflu® for the Rat		 SL-98 K. Jimbow

Utilization of Melanogenesis Substrate, NPrCAP for Exploiting Melanoma-Targeting Drug and its Conjugation with Magnetite Nanoparticles for Developing Melanoma Chemo-Thermo-Immunotherapy		 SL-99 J. Ho
Miniature Pulmonary DNA Vaccination Platform Using Microfluidic Atomization		 SL-100
3:10
3:30
p.m.
H.S. Swai

 Promising Technology in Addressing Tuberculosis Treatment - Nano Drug Delivery System		 SL-101 K. Alexandrov

Novel Cell-Free Protein Expression System Enables Rapid Production and Interaction Analysis of Recombinant Proteins		 SL-102 T. Netticadan

Potential of Resveratrol in Preventing the Development of Heart Failure		 SL-103 R. Tarnawski

Advanced MRI Imaging in Delineation of Target Volume for Radiotherapy of Differentiated Gliomas		 SL-104 E. Ruiz-Hitzky

Nanostructured Biocomposite Materials: New Insights for Biomedical Applications		 SL-105 S. Pavel

Development of Photodynamic Therapy for Larger Superficial Skin Mycoses		 SL-106 G. Fernandes

n-3 Fatty Acids Prevents Left Ventricular Hypertrophy and Bone Loss Caused by Rosiglitazone Therapy in Diabetic Aging Mice		 SL-107 C. Becker

 CD4-Mediated Activation of Human Regulatory T Cells and its Potential for Drug Development		 SL-108
3:30
3:50
p.m.
H. Lee

Design, Synthesis and Evaluation of New Steroidal Anti-Inflammatory Antidrugs 		SL-109 V. Komarov

The New Approach to Affect the Bioavailability of Solid Drugs		 SL-110 C. Szabo

The Therapeutic Potential of Hydrogen Sulfide		 SL-111 G.M. Saied

Six Months Neoadjuvant Imatinib Improves Respectability Potential of Gastric Stromal Tumors in Egyptian Patients		 SL-112 J.Y. Ljubimova

Nanobioconjugate Engineering to Treat HER2/neu Expressing Breast Tumors		 SL-113 C.-C. Chou

Differential Heat Stability of Amphenicols and their Relationship to Antimicrobial Activity: Possible Synergism after Heating Treatments		 SL-114 T. Jovanovic

Financial Benefit of the Hyperbaric Oxygenation in the Treatment of Mass Non-Infectious Diseases		 SL-115 J. Roig
Indacaterol, A Novel Inhaled, Once-Daily, Long-Acting Beta2-Agonist for the Treatment of Obstructive Airways Diseases		 SL- 116
3:50
4:10
p.m.
J. Rautio

An Effective and Selective Brain Drug Delivery via Amino Acid Prodrugs 		SL-117 C. Kaur

Melatonin's Protective Actions on the Developing Brain and Retina Against Hypoxic Damage		 SL-118 N.M. Al-Daghri

Vitamin D Status is Associated with Cardiometabolic Risk Factors Among Non-Obese Children and Adolescents		 SL-119 B. Maciejewski

Is 7-day-a-week (weekends-in) Accelerated Radiotherapy Beneficial for Locally Advanced Head & Neck Cancer: Results of Two Single-Institution Clinical Trials (CAIR-1 and CAIR-2)		 SL-120 T.V. Leshina

Synergy of Drug Transport and Efficacy: Drugs Bound to Glycyrrhizin		 SL-121 J. Sancho

Discovery of Specific Inhibitors against Helicobacter pylori by HTS of large Chemical libraries using a Protein Stability Assay		 SL-122 M.-C. Wu

Hypoglycemic Effect of Myrtaceae Family Plants in Diabetes		 SL-123 L. Valdesoiro

Effectiveness of Omalizumabin Children with Severe Asthma		 SL-124
4:10
4:30
p.m.
M. Sedlak

Nanoparticles for Cytosolic Delivery of Important Biomolecular Drug such as DNA, RNA, Peptides and Proteins 		SL-125 P. Marits

 Sentinel Node-Based Adoptive Immunotherapy of Colon Cancer 		SL-126 A.V. Maksimenko

 Enzymatic Antioxidants: Next Phase of Pharmacological Effort to Fight Oxidative Stress?		 SL-127 R. Suwinski

Implementing the Concept of Multidimensional Radiotherapy into Combined Treatment for Head and Neck Cancer)		 SL-128 P. Aranda

Bionanocomposites as Drug Delivery Systems		 SL-129 S.Y. Ablordeppey

 Novel Anti-Opportunistic Infection Agents with Lower Cytotoxicity		 SL-130 D. Shiuan

Virtual Screening for Cholesterol Biosynthesis Inhibitors		 SL-131 M. Bosque

Treatment with Omalizmab, in Children with Documented Anaphylactic Reactions to Cow's Milk Protein		 SL-132
COFFEE BREAK : 04:30 - 5:00 p.m.
 
Auditorium
Lecture Hall No.
L-115
Lecture Hall No.
E-204/205
Lecture Hall No.
B-250
Lecture Hall No.
B-114-116
Lecture Hall No. 6
(Business Faculty Area)
Lecture Hall No.
B-122
Lecture Hall No. 8
(Engineering Faculty Area)
 
 Drug Delivery   Translational Biomedical Research/Central Nervous Systems   Anti-Infectives   Oncology

 Pulmonary Disorders
 
 Chairman: A. Banga
Co-Chairman: C. Braeuchle 		Chairman: J.M. Brunel
Co-Chairman: J. Benkovic 		Chairman: S.O. Bachurin
Co-Chairman: M. Terazima		 Chairman: A. Cherkasov
Co-Chairman: S. Mughal 		Chairman: H. Lu
Co-Chairman: L. Boukraa
 Chairman: J. Fruend
Co-Chairman: G. Ghosez

Chairman: K. Pachmann
Co-Chairman: M. Tanaka

Chairman: A. Linden
Co-Chairman: J. Ho

5:00
5:20
p.m.
P. Thordarson

Self-Assembled Gels for Anti-Cancer Drug Delivery 		SL-133 M. Cemazar

Tilte Awaited		 SL-134 C.O. Rodriguez, Jr

Aerosol Gemcitabine: Preclinical Safety and In vivo Antitumor Activity in Osteosarcoma-Bearing Dogs		 SL-135 P. McCluskey

Tilte Awaited		 SL-136 G.A. Pianetti

Liquid Chromatography - Tandem Mass Spectrometry for the Simultaneous Quantitation of Artemether and Lumefantrine in Human Plasma: Application for a Pharmacokinetic Study 		SL-137 G. Ghosez

Title Awaited
 SL-138 B. Blasiak

Evaluation of Iron Based Core Nanoparticles as Targeted Contrast Agents for Molecular IR and MR Imaging of Gliomas		 SL-139 K. Khanafer
The Role of Porous Media in Modeling Fluid Flow within Hollow fiber Membranes of the Total Artificial Lungs		 SL-140
5:20
5:40
p.m.
J. Ljubimova

 Nanopolymers and Phosphodiesterase Type 5 Inhibitors for Drug Delivery into the Brain to Treat Primary Tumors and Metastases		 SL-141 M. J. Clark

Tilte Awaited		 SL-142 A.Myint

 Blood and CSF Kynurenines and Their Clinical Implications in Mood Disorders 		SL-143 M.A. Green

Tilte Awaited		 SL-144 H.Y.M. Ali

Trial of Lamivudine in Hepatitis B Surface Antigen Carriers with Persistence Hepatitis B Core IgM Antibody		 SL-145 C. M. Fusaro

Tilte Awaited		 SL-146 C.S. Chen

Molecular Characterization of resistance in multi-targeted tyrosine Kinase Inhibitors and Bcl-2 inhibitors-implication on Clinical Development of small Molecular Targeted Therapy		 SL-147 J. Morera

 Efficacy of Bosentan in the Treatment of Advanced Pulmonary Fibrosis		  SL-148

Posters Session: 1.00 p.m. - 5.00 p.m. at Corridor

Shopping Visit: Departure 6.20 p.m.

Back to Top






Plenary Session
Time Chairman: A.B. Reitz
Co-Chairman: D.K. Lahiri
Speaker
Title
09:00
09:45
a.m.
Location: Auditorium  Ferid Murad (Nobel Laureate)
 Plenary Lecture 		PL-149 Application of Nitric Oxide Research to Drug Development and Disease Therapy


Time
Auditorium
Lecture Hall No.
L-115
Lecture Hall No.
E-204/205
Lecture Hall No.
B-250
Lecture Hall No.
B-114-116
Lecture Hall No. 6 (Business Faculty Area)
Lecture Hall No.
B-122
Lecture Hall No. 8 (Engineering Faculty Area)
 
 Central Nervous System Translational Biomedical Research Cardiovascular/Developments in Other Therapeutic Areas Oncology Successful Drug Discovery from the Research Lab to the Marketplace Drug Discovery and Therapy in the Middle East: Challenges and Opportunities Nanotechnology in Biomedical Research/Proteomics & Bioinformatics/Diabetes & Obesity Regulatory Affairs

 
 Chairman: M. Hajos
Co-Chairman: G.G. Yener 		Chairman: J.L. Millan
Co-Chairman: J.J. Powell 		Chairman: D. Garcia-Dorado
Co-Chairman: A.A. Ahmed 		Chairman: E. Arinc
Co-Chairman: C.S. Chen 		Chairman: L.F. Rodella
Co-Chairman: R.J. Reiter
 Chairman: R. Chaguture
Co-Chairman: A. Pani

Chairman: G.K. Bonn
Co-Chairman: C.R.S. Garcia

Chairman: A. Hassan
Co-Chairman: V. Thatte
09:45
10:15
a.m.
P.A. Guertin

An Innovative Approach to Functional Recovery After Neurological Damage Based Upon An Hypothesis Driven-Technological Platform and Murine Models		 IL-150 C.W. Heizman

The Importance of the Calcium-Binding S100 Proteins and their Receptor RAGE in Clinical Diagnostics and as Drug Targets		 IL-151 J. Liu

An Enzymatic Approach for Preparing Synthetic Heparin		 IL-152 W. Nowicky

Ukrain (NSC 631570) in the Tretment of Prostate Cancer		 IL-153 D. Acuna-Castroviejo

Antioxidant and Anti-inflammatory Activity of the Brain Melatonin Metabolites and their Synthetic Analogs: Evaluation in Neurodegenerative Diseases		 IL-154 O. Deeb

A Novel Predictive Flip Regression Technique for QSAR of Aromatic Substances:EGFR Inhibitory Activity of Quinazoline Analogues		 IL-155 T. Webster

 In Situ Nanotechnology-Derived Sensors for Ensuring Implant Success		 IL-156 L. Batarsha

 Globalization Of the US Food and Drug Administration: International Offices/Middle East Office: Mission and Goals		 IL-157
10:15
10:45
a.m.
N.A. Khan

Acanthamoeba and Blood Brain Barrier: The Breakthrough		 IL-158 D.K. Banerjee

Targeting N-Glycans for Anti-angiogenic Therapeutics Treating Breast Cancer		 IL-159 M. Korbling

Adult Stem Cell Therapy for Injured Solid Organ Tissue		 IL-160 F. Huq

Toward New Platinums in Ovarian Cancer		 IL-161 J.M. Guerrero

Melatonin as Intracrine, Autocrine, and Paracrine Agent in Immune System: Its Role in Autoimmune Diseases		 IL-162 N.S. Turhal

Tolerability of Anthracyclines in Turkish Breast Cancer Patients		 IL-163 A. Tamaddoni-Nezhad

Systems Biology of Host-Pathogen Interaction in Campylobacter		 IL-164 Wafa Al-Khatib

 New Drug Revolution Converting fatal or debilitating Diseases into Manageable therapeutic Options		 IL-157
10.45
11:05
a.m.
S.O. Bachurin

 Multi-Target Drug Design for New Cognition-Enhancers In Series Of Glutamate-Receptors Ligands		 SL-166 R.K. Nath

Type I Collagen Antisense Oligonucleotides for the Treatment of Fibrotic Diseases		 SL-167 D.F. Maurizio

 Functional Influence of Botulinum Neurotoxin Type A 150kDa Treatment (Xeomin® of Multifocal Upper and Lower limb Spasticity on Chronic Hemiparetic Gait: A Case Report		 SL-168 M. Tanaka

Bradeion Project: Monitoring and Targeting of Cancer -- Successful Molecular Marker Diagnosis of Cancer by Fluorescence Correlation Spectroscopy (FCS)		 SL-169 G. Escames

Melatonin and its Metabolite AMK Regulate the Proliferation and Differentiation of the Mice Subventricular Neural Stem Cells. Role of Mitochondria		 SL-170 A.A. Alamolhoda

 The Metal Ions Absorption and Transportation		 SL-171 M. Dweik

Novel Implantable Nanobiosensor for Diabetics		 SL-172 Y. AlOmi

 New Model of Regional Drug and Poisoning Information Center in Saudi Arabia.
(10:45-11:15 am)
 IL-173
COFFEE BREAK : 11:05 – 11:35 a.m.
Time
Auditorium
Lecture Hall No.
L-115
Lecture Hall No.
E-204/205
Lecture Hall No.
B-250
Lecture Hall No.
B-114-116
Lecture Hall No. 6 (Business Faculty Area)
Lecture Hall No.
B-122
Lecture Hall No. 8 (Engineering Faculty Area)
 
 Global Discovery Out Sourcing/ Drug Delivery Drug Discovery and Therapy in the Middle East: Challenges and Opportunities/Central Nervous Systems/Global Discovery Outsourcing/Nanotechnology in Biomedical Research Cardiovascular /Developments in Other Therapeutic Areas Oncology Successful Drug Discovery from the Research Lab to the Marketplace Biologics/Central Nervous System

Women’s Health issues

Regulatory Affairs
(Pre/Post Marketing)

 
 Chairman: G. Fricker
Co-Chairman: B. Geusens 		Chairman: T. Al-Tel
Co-Chairman: A.A. Alamolhoda		 Chairman: J. Liu
Co-Chairman: M. Nowicki		 Chairman: W. Nowicky
Co-Chairman: B. Maciejewski 		Chairman: K. Moelling
Co-Chairman: M.H. Moghadasian 		Chairman: E. Osaro
Co-Chairman: W. Danho

Chairman: H. Borman
Co-Chairman: L. Annamalai

Chairman: M. Abulkhair
Co-Chairman: L. Batarsha

11:35
12:05
p.m.
A.K. Saha


Partnerships Between Drug Companies and CROs are Helping Shaps a New Paradigm in Drug Discovery		 IL-174 A. Pani


Pharmacologic-Induced Cholesterol Homeostatis Affects Prion Generation in a Synergistic Manner		 IL-175 M. Delmar


 Cardiac Gap Junctions as Targets for Antiarrhythmic Therapy 		IL-176 K. Pachmann


 Improving Personalized Cancer Care: Gauging the Response of Circulating Epithelial Tumor Cells (CETC) and Tumour stem Cell Subpopulations to Guide therapy in the Individual Patient 		IL-177 M. Labanca


Osteoporosis and Bone Defects in Dentistry: New Drugs and Treatment Options		 178 F.C. Onwuka


Effect of Amlodipine, A Calcium Channel Antagonist on Gonadal Steroid of Male Wistar Albino Rats		 IL-179 P. Borman
The Treatment of Postmenopausal osteoporosis: An updated Approach		 IL-180 D. Vu
Challenges and Opportunities in the Safety Surveillance of Drugs used in the Management of Autoimmune Diseases: "The Canadian Perspectives" and Applicability of the Pharmacovigilance Planning at the Drug Developmental Phase 		IL-181
12:05
12:25
p.m.
A. Mohamadzadeh


Prophylactic Effect of Clofibrate in Low Birth Weight Neonates Hyperbilirubinemia		 SL-182 F. Zerehsaz


Cutaneous Leishmaniasis, Topical, Safe, Cheap, Effective Herbal Remedy “Z-HE”		 SL-183 X.L. Zheng


Uridine Adenosine Tetraphosphate, Up4a: The New Target for Drug Development of Vascular Diseases		 SL-184 M. Bauwens

The D-Enantiomer of 2-131i-Phenylalanine as a New Promising Theragnostic in Cancer		 SL-185 W.M. Southerland

Genome-Based Drug Design: Understanding the Netropsin-DNA Interaction		 SL-186 I.S. Abuljadayel

 Retrodifferentiation: A Process of Harnessing Pluripotency Through Cell Surface Receptor Contact of more Mature Somatic Cells		 SL-187 J. Kocourkova


Demographic Aspects of Reproductive Health of Women in European Countries		 SL-188 V. Thatte
Pre-Market Evaluation and Approval of New Antibiotics in Today’s Climate - A Canadian Perspective
(12:05-12:35 pm)
 SL-189
12:25
12:45
p.m.
S.R. Savu


Application of the New Emea Rules to Study Lung Deposition ANS Systemic Exposure of Inhalers: An Evaluation in Three Antiasthmatic Drugs		 SL-190 Abolfazl-Movafagh


Application of Phytohaemagglutinin (PHA) mitogenic Effect on Cytogentic and Cell Culture Procedure		 SL-191 E. Toverud
Generic Substitution – A Challenge for Adherence in Primary Care and a Reason for Mistakes in Hospitals		 SL-192 R.-P Muller


Eight Cycles of Beacopp Escalated Compared with 4 Cycles of Beacopp Escalated Followed by 4 Cycles of Beacopp Baseline with or without Radiotherapy in Patients in Advanced Stage Hodgkin Lymphoma (HL): Final Analysis of the Randomized HD12 Trial of the German Hodgkin Study Group (GHSG)		 SL-193 A.E. Papalois
The Role of Modern Experimental Biomedical Research in the Development of New Products with Clinical Applications. The Example of the Experimental – Research Center ELPEN Pharma		 SL-194 J.L. Domingo
Metals and Alzheimer's Disease, Potential, Therapeutic Treatment with Metal Complexing Agents		 SL-195 B. Nikolic


GTN in Perimenopause and Menopause – Treatment and Outcome		 SL-196 Y. Sharif


Cough and Cold Preparations in UAE Basic Facts and New Regulation Trends

 SL-197
12:45
01:05
p.m.
N.R. Biswas


Intraocular Penetration of Orally and Intravenously Administered Fluoroquinolones in Non-Inflamed Eyes of the Patients Undergoing Vitrectomy Surgery		 SL-198 J. McGill


The Lilly Phenotypic Drug Discovery (PD2) Initiative: An Invitation to an Open Innovation Model in Drug Discovery		 SL-199 A.A. Batista


 Antimalarial Activities of Phosphine / Ruthenium Complexes		 SL-200 E. Terpos


Proteasome Inhibition Therapies in the Management of Patients with Multiple Myeloma		 SL-201 Y. Taiwo
Eli Lilly External Pharmaceutical Innovation Partnering Strategies		 SL-202 M. R. Hwu

Tilte Awaited		 SL-203 S. Jacob


Current Therapies in Irritable Bowel Syndrome		 SL-204 R.S.I. Hassan
Evaluation of Pharmaceutical Inspection Practices
(01:05:01:25 pm)

 SL-205
01:05
01:25
p.m.
K. Jomova


 The Role of Transition Metals and Irradiation in the Action of Anticancer Drug Campthothecin		 SL-206 J. Szebeni
Mechanisms and Approaches for the Prevention of Adverse Immune Reactions to Nanomedicines		 SL-207 R.S. da Silva
Nitric Oxide Donors Based on Ruthenium Complexes. Cytotoxical Photobiological and Pharmacological Aspects		 SL-208 L. Miszczyk


An Evaluation of Half-Body Irradiation (HBI) as the Treatment of Cancer Patients with Widespread, Painful Bone Metastases		 SL-209 J.J. Yu
New Platinum Drug Dicycloplatin Appears Effective in Treating Brain and Prostate Cancers		 SL-210 J. Jimeno

Tilte Awaited		 SL-211 L.C. Larabie


 Leaving the Pack Behind: Implications of Spontaneous Quitting for Women Smokers		 SL-212 Tilte Awaited
 (01:15-01:35 pm)		 SL-213
LUNCH BREAK : 1:25 – 03:00 p.m.
Time
Auditorium
Lecture Hall No.
L-115
Lecture Hall No.
E-204/205
Lecture Hall No.
B-250
Lecture Hall No.
B-114-116
Lecture Hall No. 6 (Business Faculty Area)
Lecture Hall No.
B-122
Lecture Hall No. 8 (Engineering Faculty Area)
 
 Enabling Technologies/Deve-lopments in Other Therapeutic Areas Proteomics & Bioinformatics Drug Discovery & Therapy in the Middle East: Challenges & Opportunities Cardiovascular/Oncology Endothelial Dysfunction in Cardiovascular Diseases /Nanotechnology in Biomedical Research/Pharmaceutical Biotechnology Central Nervous System Women's Health Issues Regulatory Affairs
(Genetics)
 
 Chairman: E. Toverud
Co-Chairman: P.E. Zollinger 		Chairman: P. Hobza Co-Chairman: I.H. Khan Chairman: O. Deeb
Co-Chairman: J.A. Vaz 		Chairman: M. Delmar
Co-Chairman: R. Suwinski 		Chairman: A. Roman
Co-Chairman: T. Webster		 Chairman: M. Bajbouj
Co-Chairman: N.A. Khan

Chairman: S. Jacob
Co-Chairman: L.C. Larabie

Chairman: A. Hassen
Co-Chairman: S. Ghani

03:00
3:30
p.m.
S. McN. Sieburth

Silicon-Based Protease Inhibitors - Advances in Chemistry and Applications		 IL-214 G.K. Bonn

New Analytical Technologies for Applications in Proteomics		 IL-215 V. Misik

Globalization of Pharma Development – role of Middle East		 IL-216 J. Gutkowska

Oxytocin: Old Hormone, New Drug		 IL-217 L. Dos-Surbia

 Pulmonary Hypertension in Congenital Heart Diseases. Role of Pulmonary Vasodilators Drugs in this Clinical Setting		 IL-218 A.W. Klein

Toxic Toxins: 2010		 IL-219 H. Borman

Breast Reduction in Women: Aesthetic and Health Benefits		 IL-220 S. Ghani

 Global Perspective of Stability Testing		 IL-221
3:30
3:50
p.m.
S. Grmec

Erythropoietin Facilitates the Return of Spontaneous Circulation and Survival inVictims of Out-of-Hospital Cardiac Arrest		 SL-222 R. Graziella

Forced Unbinding of GPR17 Ligands from Wild Type and R2551 Mutant Receptor Models through a Computational Approach		 SL-223 J. Hasegawa

Tilte Awaited
SL-224 C. Szczepanski

A New Lytic Peptide for the Treatment of Cancer		 SL-225 K. Karim

Smart Materials for Pharmaceutical Industry		 SL-226 F. Deschamps

 Aluminium Discovery in Occupational Health		 SL-227 L. Annamalai

 Angiogenic Factors and their Role in Uteroplacental Dysfunction		 SL-228 M. Abuelkhair

Introduction of Generic Drug Policy in the Market Place with Special Reference to the Health Authority in the Emirates of Abudhabi		 IL-229
3:50
4:10
p.m.
P. Takac

 Discovery of the Biologically Active Compounds from the Insect Salivary Glands as a Potential Drugs		 SL-230 N. Nomura

Tilte Awaited
 SL-231 M.R. F. Wessels

Tilte Awaited
 SL-232 M.H. Bukhari

 Molecular Classification of Breast Cancer and Role of Immunohistochemistry for detection of cell types that predicts response to chemotherapy 		SL-233 T. Wenyi

 Paclitaxel Production Using Co-culture of Taxus Suspension Cells and Paclitaxel-Producing Endophytic Fungi in a Co-Bioreactor		 SL-234 H. Vial

Tilte Awaited
 SL-235 O. Piccolo

Tilte Awaited
 SL-236 O. G. Al Ahdab

Pharmacoeconomics: The Fourth Hurdle to Marketing and Formulary Access 		SL-237
COFFEE BREAK : 4:10 – 5:00 p.m.
Time
Auditorium
Lecture Hall No.
L-115
Lecture Hall No.
E-204/205
Lecture Hall No.
B-250
Lecture Hall No.
B-114-116
Lecture Hall No. 6 (Business Faculty Area)
Lecture Hall No.
B-122
Lecture Hall No. 8 (Engineering Faculty Area)
 
 Oncology - Endothelial Dysfunction in Cardiovascular Diseases - Cardiovascular/ Pulmonary Disorders Central Nervous System

Anti-Infectives

 
 Chairman: M. Melnik
Co-Chairman: R. Tarnawski 		Chairman: N. Nomura Co-Chairman: J. Fruend Chairman: E. Domingo
Co-Chairman: L.Dos-Surbia
 Chairman: P. McCluskey Co-Chairman: M. A. Green Chairman: C.D. Ribas
Co-Chairman: M. Korbling 		Chairman: M. Labanca
Co-Chairman: M. Zhinan

Chairman: S.Y. Ablordeppey
Co-Chairman: J. Sancho

5:00
5:30
p.m.
 S. Pervaiz

Regulation of Mitochondrial Metabolism: Yet Another Facet in the Intriguing Biology of the Onco-Protein Bcl-2		 IL-238 Y. Wang

Title Awaited
 IL-239 F. Lozano

 Premature Ejaculation. Pharmacological Treatment 		IL-240 I. Kato

Title Awaited		 241 K. Balagurunathan

 Developments of Novel Anticoagulants		 IL-242 M. Diksic

 Imaging of Serotonin synthesis as a Factor of Serotonergic Transmission and Brain Serotonergic Receptors and Their Relation to Affective Disorders		 IL-243 H. Lu

 Utilization Analysis of Drug Efficacy of the 329 Cases of Wenchuan Earthquake Women and Children Patients		 IL-244 Title Awaited

IL-245
5:30
6:00
p.m.
R. Kumar

Role of PET and PET-CT in Anticancer Drug Development		 IL-246 J. st-Amand

Title Awaited		 IL-247 E. Ruiz-Castane

 Total Penile Reconstruction. Faloplastia		 IL-248 R.S. Wallis

Title Awaited		 IL-249 C.S. Ulrik

Anti-Inflammatory Therapy and Decline of Lung Function in Patients with Asthma		 IL-250 S. Ghandour

 Brain Drug Targeting and Noninvasive Delivery of Therapeutics		 IL-251 L. Boukraa

 Bee Products as Anti-infective Agents		 IL-252 Title Awaited


IL-253

Posters Session: 1.00 p.m: – 5.00 p.m. at Corridor

Gala Dinner at Dhow Cruise: Departure at 6:15 p.m.

The buses will leave for Hotels at: 9.00 p.m.

Back to Top






Plenary Session
Time Chairman: J. Lewis
Co-Chairman: C. Hopkins
Speaker
Title
9:00
9:45
a.m.
 Location: Auditorium David Kerr PL-254 Innovations in Cancer Drug Development

Time
Auditorium
Lecture Hall
No.
L-115
Lecture Hall No.
E-204/205
Lecture Hall No.
B-250
Lecture Hall No.
B-114-116
Lecture Hall No. 6
(Business Faculty Area)
Lecture Hall No.
B-122
Lecture Hall No. 8
(Engineering Faculty Area)
 
 Developments in Other Therapeutic Areas/Global Roundup of Pharmaceutical Research Capabilities & Opportunities Proteomics & Bioinformatics Translational Biomedical Research Global Discovery Outsourcing/Oncology Endothelial Dysfunction in Cardiovascular diseases Central Nervous System

 Inflammation & Immunology

Regulatory Affairs
(REC Local)

 
 Chairman: B.M. Dunn
Co-Chairman: A. Nefzi
 Chairman: P. Hobza
Co-Chairman: G.K. Bonn
 Chairman: J.K. Yao
Co-Chairman: L. Kostrikis
 Chairman: A.K. Saha
Co-Chairman: M. Bauwens

 Chairman: Y. Xia
Co-Chairman: E. Ruiz-Castane
 Chairman: A.W. Klein
Co-Chairman: L. Lagae		 Chairman: O. Winqvist
Co-Chairman: S. Basu

Chairman: M. Al-Farhan
Co-Chairman: K. Obaidi

9:45
10:15
a.m.
M.I. Choudhary

 Novel Pharmacophores from Natural Sources-Discovery Development		 IL-255 C.R.S. Garcia

Malaria Functional Genomics: A Plasmodium Receptor for C Kinase (PfRack) Modulates Calcium Signaling in Mammalian Cells		 IL-256 H.M. Amin

NPM-ALK+ T-Cell Lymphoma as a Model for Developing Cancer Therapeutics		 IL-257 J. Freire

Drug Discovery Outsourcing: Experiences and Learnings		 IL-258 M.A. Gomez Sanchez

 Evolution of Prostaglandins in the Treatment of Pulmonary Hypertension		 IL-259 V. Parpura

Carbon Nanotubes as Modulators of Neuronal Growth		 IL-260 C. L. Verweij

 Biomarkers in Targeted-Drug Development for Chronic Inflammatory Diseases		 IL-261 M. A. Sharifi

 Institutional Regulations for Biomedical Research: The Role of "Institutional Review Board" (IRB) 		IL-262
10:15
10:45
a.m.
C.E. Stout

Mixing Ecology and Drug Discovery. An Innovative New Model		 IL-263 I.H. Khan

New Paradigm in Tuberculosis Serodiagnosis: Computational Analysis to Classify Profiles of anti-Mtb. Antibodies Detected by Multiplex Microbead Array		 IL-264 N.J.R. Faria

Novel in vitro Assay for the Characterisation of Phosphate Binders: Efficacy of IMH-Based Materials		 IL-265 D.M. Stout

Outsourcing Drug Discovery at Merck: Future Trends		 IL-266 A. Roman

 Medical Treatment of PAH and the Role of Lung Transplantation in 2010		 IL-267 M. Bajbouj

Electromagnetic Interventions to treat Depression		 IL-268 N. Nishimoto

Tocilizumab, a New Therapeutic Antibody Inhibiting IL-6 Action, for Immune Inflammatory Diseases Inclding Rheumatoid Arthiritis and Juvenile Idiopathic Arthritis. Mechanisms of Action and Prediction for the Clinical Efficacy Using DNA Microarray		 IL-269 M.M. Al-Turki

 Research Regulations at the King Faisal Specialist Hospital and Research Centre (KFSH&RC) – Riyadh, Saudi Arabia		 IL-270
10:45
11:05
a.m.
O.L. Franco

The Utilization of Proteomics and Gel-Free Peptidomics to Find Novel Plant Antimicrobial Peptides and to Understand the Relative Bacterial Resistance		 SL-271 H. Durchschlag

Prediction of Volume, Surface, and Hydration Properties of Proteins and Other Biomolecules		 SL-272 J. Chandra

Translational Cancer Research Using Novel Clinically Relevant Proteasome Inhibitors and Histone Deacetylase Inhibitors		 SL-273 F. Andrae

 UKRAIN based Laser Therapy in Oncology		 SL-274 M. Sinz


Title Awaited		 SL-275 J.J. Greer

Development of AMPAKINE Therapy to Alleviate Drug-Induced Respiratory Depression		 SL-276 S. Zughaier
Potent Anti-inflammatory Activity of Novel Microtubule-Modulating Brominated Noscapine Analogs

SL-277 M. Zemni

Local Ethics Committees and Research: The Tunisian Experience		 IL-278
COFFEE BREAK : 11:05 - 11:35 a.m.
Time
Auditorium
Lecture Hall No.
L-115
Lecture Hall No.
E-204/205
Lecture Hall No.
B-250
Lecture Hall No.
B-114-116
Lecture Hall No. 6
(Business Faculty Area)
Lecture Hall No.
B-122
Lecture Hall No. 8
(Engineering Faculty Area)
 
 Developments in Other Therapeutic Areas/Enabling Technologies  Drug Delivery Translational Biomedical Research Oncology Successful Drug Discovery from the Research Lab to the Marketplace Central Nervous System

Inflammation & Immunology

Regulatory Affairs (REC)

 
 Chairman: P. Takac
Co-Chairman: A.A. Batista
  Chairman: H. Kasuya
Co-Chairman: H. Lee
 Chairman: D.K. Banerjee
Co-Chairman: : I.M. Shah

 Chairman: R.-P. Muller
Co-Chairman: F.Huq
 Chairman: W.M. Southerland
Co-Chairman: J.J. Yu 		Chairman: S. Ghandour
Co-Chairman: S.R. Maudsley

Chairman: C.L. Verweij
Co-Chairman: P.C. Heinrich

Chairman: M. Al Farhan
Co-Chairman: M. Zimni

11:35
11:55
a.m.
D.B. Shukla

Synergy of Intellectual Property and Traditional Knowledge		 SL-279 K.A.M. Gasem

Virtual Design of Chemical Penetration Enhancers for Transdermal Drug Delivery of Insulin		 SL-280 M. Terazima

How to Measure Translational Diffusion of Chemically Reactive Drugs		 SL-281 M. Hassan

Pharmacokinetics and Biodistribution of CDK Inhibitors as Anticancer Drugs		 SL-282 C.E.J. van Rensburg

Potassium Humate Reduces Clinica (WOMAC) and Bioligical (hs-CRP) Markers of Disease in Patients with Osteoarthritis of the Knee		 SL-283 A. Higaz

Blood Brain Barrier Permeability and tPA-Mediated Neurotoxicity		 SL-284 P. Lukasiak

Genetic Vaccine Decision Support System		 SL-285 G. Wajid

A Strategy for Streamlining Health Research in United Arab Emirates
(11:35-12:05 pm)

 SL-286
11:55
12:15
p.m.
G. Orizio

 Internet and the Drug Market: The New Scenario Created by Cyberpharmacies		 SL-287 T. Mizushima

 Therapeutic Effect of Lecithinized Superoxide Dismutase (PC-SOD) on idiopathic Pulmonary Fibrosis in Human and Bleomycin-induced Pulmonary Fibrosis in Mice		 SL-288 J.L. Millan

Leads and Target Validation for the Prevention and Treatment of Vascular Calcification		 SL-289 W. Voigt

Session Lecture:
The New Platinum Compound cis-Dichloro(2-{11-[(tetrahydro-2H-pyran-2-yl)oxy] undecyl} propan-1,3-diamino)plantin (II) overcomes CDDP resistance and induces a DNA-independent and caspase-independent apoptotic cell death in testicular cancer 		SL-290 J.A. Vaz

Challenges in Clinical Drug Development 		SL-291 N.N. Gorgani

 Ring Stabilizers: Compounds that Increase Dynamin GTPase Activity by Promoting Ring Assembly		 SL-292 A.Rengasamy

Utilization of Translational "Bench-to-Bedside" Clinical Protocols to Elucidate the Roles of FK Binding Proteins and Cyclophilins in Mediating Human T cell-Mediated Macrophage Activation		 SL-293 G. Al Tajir

 Research Ethics Committee in the UAE
 SL-294
12:15
12:35
p.m.
P.E. Zollinger

The Administration of Vitamin C in Prevention of CRPS-I in Traumatology and Orthopaedic Surgery		 SL-295 B.M. Wozniewicz

 Discovery of the New Biotechnological Procedure of Generation and Identification of Thymic Epithelial Progenitor Cells by In vitro Processing of Hyman Thymic Fragments for Allotransplantation – Possible Clinical Application in Aging Carriers		 SL-296 J.J. Powell

IMH-Based Materials Bind Dietary Phosphate Effectively In Vivo 		SL-297 R.M.A. Marretta

Session Lecture:
On Cancer Cell Cycle and Universal Apoptosis Parameters Signaling Unravelled in Silico		 SL-298 S.S. Redzic

 The Endemic Vascular Plants as a Source of New Medicines		 SL-299 Y. Iwasaki

Atrovastratin Protects Spinal Motor Neurons from Glutamate Mediated Neurotoxicity		 SL-300 J. Xiang

 A Distinct Role of CD4+ Th17 and Th17-stimulated CD8+ CTL in Induction of Experimental Autoimmune Encephalomyelitis and Antitumor Immunity		 SL-301 T. Antoinne

 Research Ethics Committees MENA Watch
(12:25-12:45 pm)

 SL-302
12:35
12:55
p.m.
G.Bodenhausen

Prospects of Drug Discovery by NMR Enhanced by Dynamic Nuclear Polarization		 SL-303 M.B. Bolger
Nanoparticle Dissolution and Absorption: Biopharmaceutics Physical Pharmacy, and Simulation		 SL-304 L. Kostrikis

HIV-1 Integrase Inhibitors: Role of Natural Diversity on Drug Efficacy and Resistance		 SL-305 M. El Habbash

Progress in Rituximab 		SL-306 G. Simon

Title Awaited		 SL-307 V. Brabec

Title Awaited		 SL-308 D. Delgado

The Human Leukocyte Antigen-G Molecule: A Novel Marker and Therapeutic Tool in Human Transplantation		 SL-309 H. Gharibyar

Oversight of Clinical Research – The Health Authority Abu Dhabi Perspective		 SL-310


LUNCH BREAK 12:55 - 2:15 p.m.
Time
Auditorium
Lecture Hall No.
L-115
Lecture Hall No.
E-204/205
Lecture Hall No.
B-250
Lecture Hall No.
B-114-116
Lecture Hall No. 6
(Business Faculty Area)
Lecture Hall No.
B-122
Lecture Hall No. 8
(Engineering Faculty Area)
 
 Generic Pharmaceuticals: Challenges and Opportunities/Developments in Other Therapeutic Areas Successful Drug Discovery from the Research Lab to the Market Place/ Drug Discovery & Therapy in the Middle East: Challenges & Opportunities Translational Biomedical Research/Nanotechnology in Biomedical Research Endothelial Dysfunction in Cardiovascular Diseases /Oncology Biologics Central Nervous System

Inflammation & Immunology

Anti-Infectives
 
 Chairman: M.I. Choudhary
Co-Chairman: S. Grmec

 Chairman: R. Mora-Ripoll
Co-Chairman: D.L. Vesely
 Chairman: C.W. Heizman
Co-Chairman: J. Jimbow

 Chairman: N.H. Hadi
Co-Chairman: L. Miszczyk

 Chairman: E. Osaro
Co-Chairman: C. Godwin  		 Chairman: J.J. Greer
Co-Chairman: V. Parpura

Chairman: O. Winqvist
Co-Chairman: J. Xiang

Chairman: G.A. Pianetti
Co-Chairman: S. Hasnain

02:15
02:45
p.m.
M. Nowicki

Biosimilar Medical Agents Approval in the European Union - a Short but Fascinating Story		 IL-311 P. Watt

 Phylomer Libraries as a Rich Source of Potent Bioactive Peptides		 IL-312 I.M. Shah


Pharmacogenetics of Cytochrome 2D6: A Translational Medicine Perspective		 IL-313 R. A. Torres

 New Concepts in the Non Invasive Evaluation of Remodeling of the Right Ventricle in Pulmonary Arterial Hypertension: Future Targets for Drug Evaluation		 IL-314 J. Weigelt

 Systematic Generation of Renewable Antibodies for Epigenetic Proteins to Enable Target Validation		 IL-315 L. Lagae

 The Need for New Treatment Options in Refractory Epilepsy		 IL-316 S. Basu

Novel Bioactive Prostaglandins and Isoprostanes in Health and Inflammatory Diseases		 IL-317 B.L. Tekwani

Global Challenges for New Drug Discovery Against Tropical Parasitic Diseases: Multidirectional Molecular Targets-Based Strategies		 IL-318
02:45
03:05
p.m.
Z. Kacarevic-Popovic

On the Use of Radiation Technology for Nanoscale Engineering of Silver/Hydrogel Based Nanocomposites for Potential Biomedical Application		 SL-319 D. Lazic

Destruction and Autodestruction Versus Maladaptation and Drug Therapy		 SL-320 H. Fenniri

Self-Assembled Nano-scaffolding for Tissue engineering and Drug Delivery		 SL-321 A.A. Udelnow

Omeprazole inhibits Proliferation and Induces Autophagy in Pancreatic Cancer Cells 		SL-322 W. Danho

Therapeutic Peptides: Opportunities and Challenges		 SL-323 S.R. Maudsley

 Bioinformatic Approaches to Signaling/Metabolic Pathways Analysis. Crucial Tools for Novel Therapeutic Design		 SL-324 A.J. Melendez

Role of SphK1 in TLRs Signaling and Sepsis: Therapeutic Inhibition of SphK1 is Protective in Experimental Endotoxin shock and Polymicrobial Sepsis		 SL-325 S. Farshad

 Emergence of Multi Drug Resistant Strains of s Isolated from Urinary Tract Infection		 SL-326
03:05
03:25
p.m.
A.A. Ahmed

 Role of Pathology and Immunohistochemistry in the Modern Era of Molecular Therapy		 SL-327 D. Macesic-Petrovic

 Behavioral Disorders and Drug Therapy		 SL-328 C. Mello

Microstructures Formation in a Seemingly Ideal Homogeneous Mixture of Ethanol and Methanol: An Experimental Evidence and Two-Dimensional Correlation Spectroscopy Approach		 SL-329 N. Kasahara

 Preclinical Development and Clinical Translation of Tumor-Selectively Replicating Retrovirus Vectors		 SL-330 J. Watson

Session Lecture: Cell Based Bioassays for the Validation of Biosimilars 		SL-331 M. Zhinan

Loureirin B: A Novel Chemical Component which can Modulate Voltage-gated Sodium Currents through TRPV1 Receptor		 SL-332 P.C. Heinrich

 A Fusion Protein of the Ligand – Binding Domain of the IL-6 Receptor Alpha and the Signal Transducer gp130 Acts as a Highly Potent and Specific Inhibitor of Human IL-6		 SL-333 E.H.A. Kamel

 Cymetiron (Hepron-BM) as Initial Treatment for Chronic Hepatitis C		 SL-334
03:25
03:45
p.m
R.A. Assaly

Title Awaited		 SL-335 N.S. Trotter

Title Awaited		 SL-336 L.-J. Fortin

Title Awaited		 SL-337 J. Liu

Effect of One Low Molecular Weight Polysaccharide (LMW-ABP) from Agaricus blazei on Inhibiting Sialyl Lewis X/E-Selectin-Mediated Metastatic Potential in HT-29 Cells and its Mechanism		 SL-338 D. Coster

Biologics for Eye Disease		 SL-339 Y. Xia

Activation of δ-Opioid Receptors Protects Against Anoxic Disruption of Ionic Homeostasis in the Cartex		 SL-340 M. Weber

 The Intravenous Laser Blood Irradiation, a new Therapeutic Approach in Immunology and Cancer Therapy		 SL-341 C.G. de Oliveira

Title Awaited		 SL-342



COFFEE BREAK : 3:45 – 4:15 p.m.
Time
Auditorium
Lecture Hall No.
L-115
Lecture Hall No.
E-204/205
Lecture Hall No.
B-250
Lecture Hall No.
B-114-116
Lecture Hall No. 6 (Business Faculty Area)
Lecture Hall No.
B-122
Lecture Hall No. 8 (Engineering Faculty Area)
 
 Successful Drug Discovery from the Research Lab to the Market Place Developments in Other Therapeutic Areas Translational Biomedical Research   Global Roundup of Pharmaceutical Research Capabilities & Opportunities  

 

 
 Chairman: T. Tallberg
Co-Chairman: D. Acuna-Castroviejo

 Chairman: R.S. da Silva
Co-Chairman: D.B. Shukla 		Chairman: A. Mufti
Co-Chairman: K.A. Baig




 Chairman: J.M. Brunel
Co-Chairman: M. Barton



 Chairman: C.E. Stout
Co-Chairman: A.B. Reitz
 		 Chairman: A. Cherkasov
Co-Chairman: H. Conoly 		Chairman: M. Cemazar Co-Chairman: M. J. Clark Chairman: P. McCluskey
Co-Chairman: G. Ghosez
04:15
04:45
p.m
M.H. Moghadasian

Cycloartenol: A New Dietary Agent with Significant Cardiovascular Benefits 		IL-343 K.M.A. Gasem

 Effect of Different Enhancers on the Transdermal Permeation of Insluin Analogs		 IL-344 O.A. Gressner

 Identification of Paraxanthine as the Most Potent Inhibitor of Hepatocellular Connective Tissue Growth Factor Expression Among the Three Primary Caffeine Metabolites		 IL-345 S.A. Day

Title Awaited		 IL-346 A.K. Saha

 Outline of Drug Discovery Partnerships between Western Pharma and Indian Laboratories		 IL-347 C.K. Rha

Title Awaited		 IL-348 H.T. Wehrens

Title Awaited		 IL-349 N. Bela

Title Awaited		 IL-350



Posters Session: 1.00 p.m. – 5.00 p.m. at Corridor

City visit: Departure: 5.30 p.m.

IMPORTANT: The buses will leave daily from all Hotels at 8.15 a.m. for the conference venue.

Back to Top



| Conferences & Trade shows |
[Webmaster]   Copyright © 2010 2nd International Conference on Drug Design & Therapy